Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1307 |
---|---|
Product Name | Anti-Dabigatran Etexilate Mesylate Recombinant Antibody |
Molecular Name | Idarucizumab |
Alias | Anti-Dabigatran Etexilate Mesylate Recombinant Antibody, Research Grade Idarucizumab |
CAS Number | 1362509-93-0 |
Target | dabigatran etexilate mesylate[Drug] |
Isotype | Fab |
Clonity | Monoclonal |
Host | Mouse |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | IP, IF, FuncS, FCM, Neut, ELISA, IHC, PK, Activ |
Buffer | PBS, pH7.5 |
Background | Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by Boehringer Ingelheim. One study sponsored by the manufacturer found that idarucizumab effectively reversed anticoagulation caused by dabigatran within minutes. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |